Factors Associated with Multi-Drug-Resistant Non-Typhoidal Salmonella in the Invasive Disease, Thailand

References

• Stanaway JD, Parisi A, Sarkar K.; Collaborators GBDN-TSID. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the global burden of disease study 2017. Lancet Infect Dis. 2019;19(12):1312–1324. doi:10.1016/S1473-3099(19)30418-9
   PubMed Web of Science ®Google Scholar
• Park SE, Pak GD, Aaby P, et al. The relationship between invasive nontyphoidal Salmonella disease, other bacterial bloodstream infections, and malaria in Sub-Saharan Africa. Clin Infect Dis. 2016;62:S23–S31. doi:10.1093/cid/civ893
   PubMed Web of Science ®Google Scholar
• Vugia DJ, Samuel M, Farley MM, et al. Invasive Salmonella infections in the United States, foodNet, 1996–1999: incidence, serotype distribution, and outcome. Clin Infect Dis. 2004;38:S149–S156. doi:10.1086/381581
   PubMed Web of Science ®Google Scholar
• Parisi A, Crump JA, Glass K, et al. Health outcomes from multidrug-resistant Salmonella infections in high-income countries: a systematic review and meta-analysis. Foodborne Pathog Dis. 2018;15:428–436. doi:10.1089/fpd.2017.2403
   Web of Science ®Google Scholar
• Chen CY, Hsieh PH, Chang CY, et al. Molecular epidemiology of the emerging ceftriaxone resistant non-typhoidal Salmonella in southern Taiwan. J Microbiol Immunol Infect. 2019;52(2):289–296. doi:10.1016/j.jmii.2018.08.007
   Google Scholar
• Li WC, Huang FY, Liu CP, et al. Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to the production of CTX-M-14 and CMY-2 beta-lactamases. J Clin Microbiol. 2005;43(7):3237–3243. doi:10.1128/JCM.43.7.3237-3243.2005
   Web of Science ®Google Scholar
• Jain P, Chowdhury G, Samajpati S, et al. Characterization of non-typhoidal Salmonella isolates from children with acute gastroenteritis, Kolkata, India, during 2000–2016. Braz J Microbiol. 2020;51(2):613–627. doi:10.1007/s42770-019-00213-z
   Web of Science ®Google Scholar
• Lee K, Yong D, Yum JH, Kim HH, Chong Y. Diversity of TEM-52 extended-spectrum beta-lactamase-producing non-typhoidal Salmonella isolates in Korea. J Antimicrob Chemother. 2003;52(3):493–496. doi:10.1093/jac/dkg385
   Web of Science ®Google Scholar
• Narasanna R, Chavadi M, Chandrakanth K. Prevalence of multidrug-resistant Salmonella typhi in typhoid patients and detection of blaCTX-M2 and blaCTX-M9 genes in cefotaxime-mediated extended spectrum β-lactamase-producing Salmonella typhi isolates. Biomed Res. 2018;29(14):3015–3021. doi:10.4066/biomedicalresearch.29-18-794
   Google Scholar
• National Antimicrobial Resistant Surveillance Center T. The situation of drug resistance 2000–2020 (6M); 2020.
   Google Scholar
• Chang YJ, Chen YC, Chen NW, et al. Changing antimicrobial resistance and epidemiology of non-typhoidal salmonella infection in Taiwanese children. Front Microbiol. 2021;29:648008. doi:10.3389/fmicb.2021.648008
   Web of Science ®Google Scholar
• Woh PY, Yeung MPS, Goggins WB, et al. Genomic epidemiology of multidrug-resistant nontyphoidal salmonella in young children hospitalized for gastroenteritis. Microbiol Spectrum. 2021;9(1):e0024821. doi:10.1128/Spectrum.00248-21
   Web of Science ®Google Scholar
• Harb A, O’Dea M, Hanan ZK, Abraham S, Habib I. Prevalence, risk factors and antimicrobial resistance of Salmonella diarrhoeal infection among children in Thi-Qar Governorate, Iraq. Epidemiol Infect. 2017;145(16):3486–3496. PMID: 29103396; PMCID: PMC9148757. doi:10.1017/S0950268817002400
   Web of Science ®Google Scholar
• Hengkrawit K, Tangjade C. Prevalence and trends in antimicrobial susceptibility patterns of multi-drug-resistance non-typhoidal salmonella in Central Thailand, 2012–2019. Infect Drug Resist. 2022;15:1305–1315. doi:10.2147/IDR.S355213
   Web of Science ®Google Scholar
• World health organization. 2014-2016 ICD-10-CM Diagnosis Code A02.0-02.9 Salmonella infection. Available from: https://www.icd10data.com/ICD10CM/Codes/A00-B99/A00-A09/A02-/A02.9. Accessed June 30, 2019.
   Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Bureau of Laboratory Quality S. History and Authority. Available from: http://blqs.dmsc.moph.go.th/en/page-view/22. Accessed June 30, 2019.
   Google Scholar
• Magiorakos A, Srinivasan RB, Carey Y, et al. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Uche IV, MacLennan CA, Saul A. A systematic review of the incidence, risk factors and case fatality rates of invasive nontyphoidal salmonella (iNTS) Disease in Africa (1966 to 2014). PLoS Negl Trop Dis. 2017;11(1):e0005118. PMID: 28056035; PMCID: PMC5215826. doi:10.1371/journal.and.0005118
   PubMed Web of Science ®Google Scholar
• Chang YJ, Chen YC, Chen NW, et al. Changing antimicrobial resistance and epidemiology of non-typhoidal salmonella infection in Taiwanese children. Front Microbiol. 2021;12:648008. PMID: 33868207; PMCID: PMC8044818. doi:10.3389/fmicb.2021.648008
   Web of Science ®Google Scholar
• Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33(Suppl 3):C21–9. PMID: 25912288; PMCID: PMC4469558. doi:10.1016/j.vaccine.2015.03.102
   PubMed Web of Science ®Google Scholar
• Guyomard-Rabenirina S, Muanza B, Bastian S, et al. Salmonella enterica serovars panama and arechavaleta: risk factors for invasive non-typhoidal salmonella disease in Guadeloupe, French West Indies. Am J Trop Med Hyg. 2018;99(3):584–589. PMID: 30014811; PMCID: PMC6169165. doi:10.4269/ajtmh.18-0192
   Web of Science ®Google Scholar
• Ke Y, Lu W, Liu W, Zhu P, Chen Q, Zhu Z. Non-typhoidal Salmonella infections among children in a tertiary hospital in Ningbo, Zhejiang, China, 2012–2019. PLoS Negl Trop Dis. 2020;14(10):e0008732. PMID: 33017418; PMCID: PMC7561262. doi:10.1371/journal.pntd.0008732
   PubMed Web of Science ®Google Scholar
• Guyomard-Rabenirina S, Muanza B, Bastian S, et al. Multi-drug resistant non-typhoidal Salmonella associated with invasive disease in western Kenya. PLoS Negl Trop Dis. 2018;12(1):e0006156. PMID: 29329299; PMCID: PMC5785031. doi:10.1371/journal.pntd.0006156
   Web of Science ®Google Scholar
• World health organization. Ageing and health; 2022. Available from:https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed November 3, 2022.
   Google Scholar
• Navaneeth BV, Tripathi R, Abbas M, Belwadi MR. Subcutaneous abscess caused by extended-spectrum beta-lactamase-producing Salmonella senftenberg in a type 2 diabetic--a case report. Int J Infect Dis. 2002;6(4):321–322. PMID: 12725214. doi:10.1016/s1201-9712(02)90170-0
   Google Scholar
• Shen CH, Lin YS, Chang FY. Gas-forming parotid abscess in a diabetic patient: an unusual complication of Salmonella enteritidis bacteremia. Am J Med Sci. 2008;336(6):504–507. PMID: 19092325. doi:10.1097/MAJ.0b013e3181626545
   Web of Science ®Google Scholar
• Fukuda T, Bouchi R, Minami I. Retrograde pyelonephritis and lumbar spondylitis as a result of Salmonella typhi in a type 2 diabetes patient with neurogenic bladder. J Diabetes Investig. 2016;7(3):436–439. doi:10.1111/jdi.12375
   Web of Science ®Google Scholar
• Matono T, Takeshita N, Kutsuna S, et al. Indolent non-typhoidal salmonella vertebral osteomyelitis in a diabetic patient. Intern Med. 2015;54(23):3083–3086. PMID: 26631898. doi:10.2169/internalmedicine.54.4833
   Web of Science ®Google Scholar
• Raine T, Zaccone P, Mastroeni P, Cooke A. Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol. 2006;177(4):2224–2233. PMID: 16887982. doi:10.4049/jimmunol.177.4.2224
   Web of Science ®Google Scholar
• Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3–4):259–265. doi:10.1111/j.1574-695X.1999.tb01397
   PubMedGoogle Scholar
• Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379(9835):2489–2499. PMID: 22587967; PMCID: PMC3402672. doi:10.1016/S0140-6736(11)61752-2
   PubMed Web of Science ®Google Scholar
• Mermin J, Lule J, Ekwaru JP, et al. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS. 2005;19(10):1035–1042. PMID: 15958834. doi:10.1097/01.aids.0000174449.32756.c7
   PubMed Web of Science ®Google Scholar
• Gordon MA, Banda HT, Gondwe M, et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS. 2002; (12):1633–1641. PMID: 12172085. doi:10.1097/00002030-200208160-00009
   Web of Science ®Google Scholar
• Kiratisin P. Bacteraemia due to non-typhoidal Salmonella in Thailand: clinical and microbiological analysis. Trans R Soc Trop Med Hyg. 2008;102(4):384–388. PMID: 18321543. doi:10.1016/j.trstmh.2008.01.019
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatric. Samonella. In: Kimberlin D, Barnett ED, Lynnfield R, Sawyer MH, editors. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021:655–662.
   Google Scholar
• Sumpradit N, Chongtrakul P, Anuwong K, et al. Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ. 2012;90(12):905–913. PMID: 23284196; PMCID: PMC3524958. doi:10.2471/BLT.12.105445
   PubMed Web of Science ®Google Scholar
• World health organization. Antimicrobial stewardship interventions: a practical guide; 2022. Available from:https://apps.who.int/iris/bitstream/handle/10665/340709/9789289054980-eng.pdf. Accessed November 3, 2022.
   Google Scholar